Michelle Darling, BS (she/her/hers)

Senior Clinical Program Manager
Inhibrx, Inc

Michelle is a Senior Clinical Program Manager with Inhibrx, INC. Michelle Darling has over 16 years in the Clinical Research Industry and has worked as a global project lead working across phase I-IV of clinical research with her therapeutic expertise encompassing many different indications.
Michelle is currently the Global lead of Ph2 INBRX-109 SA CS Study. She is currently home based in Mebane, North Carolina.

Poster(s):

• (P 315) A RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 TRIAL OF INBRX-109 IN UNRESECTABLE OR METASTATIC CONVENTIONAL CHONDROSARCOMA